Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer’s disease mouse model by regulating the expression of APP secretasesMiaomiao Zhang, Weidong Li|Alzheimer s Research & Therapy|2024Cited by 36
Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the Alzheimer's disease mouse model by regulating the expression of App secretasesMiaomiao Zhang, Weidong Li|Research Square|2023Cited by 0